Does OMALIZUMAB Cause Lung neoplasm malignant? 162 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Lung neoplasm malignant have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.3% of all adverse event reports for OMALIZUMAB.
162
Reports of Lung neoplasm malignant with OMALIZUMAB
0.3%
of all OMALIZUMAB reports
9
Deaths
34
Hospitalizations
How Dangerous Is Lung neoplasm malignant From OMALIZUMAB?
Of the 162 reports, 9 (5.6%) resulted in death, 34 (21.0%) required hospitalization, and 7 (4.3%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which OMALIZUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS